A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Roche inks $200M pact for Freenome's cancer screening blood test - Fierce Biotech
Roche inks $200M pact for Freenome's cancer screening blood test Fierce Biotech
Roche's oral SERD goes 2 for 2, hitting goal in phase 3 adjuvant breast cancer trial - Fierce Biotech
Roche's oral SERD goes 2 for 2, hitting goal in phase 3 adjuvant breast cancer trial Fierce Biotech
Roche reports phase 3 multiple sclerosis wins for BTK inhibitor, succeeding where rivals failed - Fierce Biotech
Roche reports phase 3 multiple sclerosis wins for BTK inhibitor, succeeding where rivals failed Fierce Biotech
Roche signs $2B pact to pilot Manifold Bio's shuttles to the brain - Fierce Biotech
Roche signs $2B pact to pilot Manifold Bio's shuttles to the brain Fierce Biotech
Roche pens $1B biobucks deal for Chinese company's respiratory disease bispecific - Fierce Biotech
Roche pens $1B biobucks deal for Chinese company's respiratory disease bispecific Fierce Biotech
Roche axes 4 Chugai solid tumor assets in early-phase clear-out - Fierce Biotech
BIOTECH Roche axes 4 Chugai solid tumor assets in early-phase clear-out By Nick Paul Taylor Oct 23, 2025 4:53am Roche Chugai solid tumor endometriosis Roche has dropped...
China pricing pressure continues to weigh on Roche's diagnostics business - Fierce Biotech
China pricing pressure continues to weigh on Roche's diagnostics business Fierce Biotech
Roche nabs FDA clearance for Alzheimer's biomarker blood test - Fierce Biotech
Roche nabs FDA clearance for Alzheimer's biomarker blood test Fierce Biotech
Roche's 'top three' obesity ambition not reliant on developing one megablockbuster - Fierce Biotech
Roche's 'top three' obesity ambition not reliant on developing one megablockbuster Fierce Biotech
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page